Membership Home Portfolio Stocks Bonds Funds ETFs CEFs Markets Tools Real Life Finance Discuss
 

ETFS Holding Bayer AG

ETFS Holding Bayer AG (5)
Stock Quotes for Bayer AG (4)
News Articles for Bayer AG (11)
 
ETFS Holding Bayer AG top ^
ewg - iShares MSCI Germany Index
  • Holdings: Top Holdings EWG More..., Siemens AG, Bayer AG, Basf SE, Sap AG, Allianz SE
  • Category: Miscellaneous Region
  • Morningstar Rating: 3 Stars
View Price Quote for ewg - iShares MSCI Germany Index
Sign-up for ewg investment picks
ezu - iShares MSCI EMU Index
  • Holdings: Top Holdings EZU More..., Sanofi, Total SA, Siemens AG, Bayer AG, Basf SE
  • Category: Europe Stock
  • Morningstar Rating: 1 Stars
View Price Quote for ezu - iShares MSCI EMU Index
Sign-up for ezu investment picks
fez - SPDR EURO STOXX 50
  • Holdings: Top Holdings FEZ More..., Sanofi, Total SA, Bayer AG, Basf SE, Siemens AG
  • Category: Europe Stock
  • Morningstar Rating: 1 Stars
View Price Quote for fez - SPDR EURO STOXX 50
Sign-up for fez investment picks
iry - SPDR S&P International HealthCare Sector
  • Holdings: Top Holdings IRY More..., Novartis AG, Roche Holding AG, Sanofi, GlaxoSmithKline PLC, Bayer AG
  • Category: Health
  • Morningstar Rating: 3 Stars
View Price Quote for iry - SPDR S&P International HealthCare Sector
Sign-up for iry investment picks
hedj - WisdomTree Europe Hedged Equity
  • Holdings: Top Holdings HEDJ More..., Bayer AG, Unilever NV DR, Anheuser-Busch Inbev SA, Sanofi, Daimler AG
  • Category: Europe Stock
  • Morningstar Rating: 4 Stars
View Price Quote for hedj - WisdomTree Europe Hedged Equity
Sign-up for hedj investment picks

 
Stock Quotes for Bayer AG top ^
bayry - Bayer AG ADR
  • Industry: Drug Manufacturers - Major
  • Sector: Healthcare
  • Stock Style: Large Growth
  • Morningstar Rating: 2 Stars
View more bayry analysis
Sign-up for bayry investment picks
bayry - Bayer AG ADR
  • Industry: Drug Manufacturers - Major
  • Sector: Healthcare
  • Stock Style: Large Growth
  • Morningstar Rating: 2 Stars
View Price Quote for bayry - Bayer AG ADR
Sign-up for bayry investment picks
bayry%20n - Bayer AG ADR
  • Industry: Drug Manufacturers - Major
  • Sector: Healthcare
  • Stock Style: Large Growth
View Price Quote for bayry%20n - Bayer AG ADR
Sign-up for bayry%20n investment picks
bayn - Bayer AG
  • Industry: Drug Manufacturers - Major
  • Sector: Healthcare
  • Stock Style: Large Growth
  • Morningstar Rating: 2 Stars
View Price Quote for bayn - Bayer AG
Sign-up for bayn investment picks

 
News Articles for Bayer AG top ^
2013/2/19
Regeneron and Bayer Initiate Phase 3 Trial of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema in Asia and Russia
TARRYTOWN, N.Y. and BERLIN , Feb.
View more Regeneron and Bayer Initiate Phase 3 Trial of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema in Asia and Russia analysis
Sign-up for Regeneron and Bayer Initiate Phase 3 Trial of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema in Asia and Russia investment picks
2013/2/25
Bayer's Stivarga® (regorafenib) Tablets Approved by U.S. FDA for Treatment of Patients with Locally Advanced, Unresectable or Metastatic GIST
WAYNE, N.J. and SOUTH SAN FRANCISCO, Calif.
View more Bayer's Stivarga® (regorafenib) Tablets Approved by U.S. FDA for Treatment of Patients with Locally Advanced, Unresectable or Metastatic GIST analysis
Sign-up for Bayer's Stivarga® (regorafenib) Tablets Approved by U.S. FDA for Treatment of Patients with Locally Advanced, Unresectable or Metastatic GIST investment picks
2013/3/25
Bayer's Stivarga® (regorafenib) Tablets Approved in Japan
WAYNE, N.J. and SOUTH SAN FRANCISCO, Calif.
View more Bayer's Stivarga® (regorafenib) Tablets Approved in Japan analysis
Sign-up for Bayer's Stivarga® (regorafenib) Tablets Approved in Japan investment picks
2013/3/28
Syngenta and Bayer CropScience Propose a Comprehensive Action Plan to Help Unlock EU Stalemate on Bee Health
BASEL, Switzerland , March 28, 2013 /PRNewswire/ -- Syngenta is one of the world's leading companies with more than 27,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life.
View more Syngenta and Bayer CropScience Propose a Comprehensive Action Plan to Help Unlock EU Stalemate on Bee Health analysis
Sign-up for Syngenta and Bayer CropScience Propose a Comprehensive Action Plan to Help Unlock EU Stalemate on Bee Health investment picks
2013/4/16
Bayer and Monsanto Enter Into Licensing Agreements
Germany's Bayer AG (BAYN.XE) said Tuesday its CropScience unit and Monsanto Co.
View more Bayer and Monsanto Enter Into Licensing Agreements analysis
Sign-up for Bayer and Monsanto Enter Into Licensing Agreements investment picks
2013/4/16
Bayer CropScience And Monsanto Enter Into Cross-Licensing Agreements For Next-Generation And Enabling Technologies
Agreements Create More Options for Farmers and Expanded Market Opportunities for Next-Generation Technologies MONHEIM, Germany and ST.
View more Bayer CropScience And Monsanto Enter Into Cross-Licensing Agreements For Next-Generation And Enabling Technologies analysis
Sign-up for Bayer CropScience And Monsanto Enter Into Cross-Licensing Agreements For Next-Generation And Enabling Technologies investment picks
2013/4/16
Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin Solution (BAY41-6551T) in Mechanically Ventilated Patients with Gram-negative Pneumonia
WAYNE, N.J. , April 16, 2013 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. announced today that patient enrollment is underway in its global Phase III trial program to evaluate the efficacy and safety of adjunctive aerosolized BAY41-6551 versus aerosolized placebo in the treatment of intubated and mechanically ventilated patients with Gram-negative pneumonia receiving standard of care intravenous antibiotics.
View more Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin Solution (BAY41-6551T) in Mechanically Ventilated Patients with Gram-negative Pneumonia analysis
Sign-up for Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin Solution (BAY41-6551T) in Mechanically Ventilated Patients with Gram-negative Pneumonia investment picks
2013/4/30
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Conceptus, Inc. in Connection with the Sale of the Company to Bayer HealthCare LLC
Levi & Korsinsky is investigating the Board of Directors of Conceptus, Inc. (“Conceptus” or the “Company”) (NasdaqGS: CPTS) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Bayer HealthCare LLC.
View more SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Conceptus, Inc. in Connection with the Sale of the Company to Bayer HealthCare LLC analysis
Sign-up for SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Conceptus, Inc. in Connection with the Sale of the Company to Bayer HealthCare LLC investment picks
2013/4/30
Stepan Announces Agreement To Acquire North American Polyester Resins Business From Bayer
NORTHFIELD, Ill.
View more Stepan Announces Agreement To Acquire North American Polyester Resins Business From Bayer analysis
Sign-up for Stepan Announces Agreement To Acquire North American Polyester Resins Business From Bayer investment picks
2013/4/29
Conceptus INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Conceptus, Inc. Following Announcement of Proposed Sale of Company to Bayer HealthCare, LLC
Former Attorney General of Louisiana, Charles C.
View more Conceptus INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Conceptus, Inc. Following Announcement of Proposed Sale of Company to Bayer HealthCare, LLC analysis
Sign-up for Conceptus INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Conceptus, Inc. Following Announcement of Proposed Sale of Company to Bayer HealthCare, LLC investment picks
2013/4/29
Acquisition of Conceptus, Inc. by Bayer HealthCare LLC May Not Be in the Best Interests of Conceptus Shareholders
SAN DIEGO and MOUNTAIN VIEW, Calif.
View more Acquisition of Conceptus, Inc. by Bayer HealthCare LLC May Not Be in the Best Interests of Conceptus Shareholders analysis
Sign-up for Acquisition of Conceptus, Inc. by Bayer HealthCare LLC May Not Be in the Best Interests of Conceptus Shareholders investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Site Directory Site Map Our Products
Corrections Help Advertising Opportunities Licensing Opportunities Glossary RSS Mobile Portfolio Affiliate Careers Company News
ETFS Holding Bayer AG
Stocks by:
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry
Mutual Funds by:
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title
ETFs by:
Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name
Articles by:
Title |  Date |  Author |  Collection |  Interest |  Popularity
Premimum Stocks by:
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry
Premimum Funds by:
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title
Premimum ETFs by:
Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name
Popular Articles by:
Title |  Date |  Author |  Collection |  Popularity |  Interest
SEC Filings by:
Title |  Date |  Company |  Symbol |  Interest |  Popularity
Popular SEC Filings by:
Title |  Date |  Company |  Symbol |  Interest |  Popularity
Investment Categories by:
Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: ETFS Holding Basf SE  |  Next: ETFS Holding Baytex Energy Corp
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.

© Copyright 2013 Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.